AzTrials
AzTrials

Autism Spectrum Disorder (ASD)NTT-SCEDNCT07797439

Neuromotor Task Training in Autistic Children With Motor Difficulties

A study testing Neuromotor Task Training in people with Autism Spectrum Disorder (ASD), run by Groupe Hospitalier Nord-Essonne at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical study is to learn whether Neuromotor Task Training (NTT) may help improve functional motor skills in autistic children who have motor difficulties. The main question it aims to answer is: Does Neuromotor Task Training help autistic children improve a motor skill that is difficult for them in… Read more about this study

Who is it for?
Ages 6 to 10 years
Conditions the study is for
Autism Spectrum Disorder (ASD)
What is being tested?
Neuromotor Task Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteFrance
Study dates
Oct 2026to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 6 to 10 years.
  • Diagnosis of autism spectrum disorder.
  • Presence of motor difficulties documented by clinical assessment and/or standardized motor assessment.
  • Ability to understand and participate in the proposed motor training sessions.
  • Written informed consent from the child's legal representative(s).
  • Child assent whenever possible, according to age and level of understanding.
  • Participation in the usual care pathway at the investigating center.

Who cannot join

  • Intelligence quotient below 70, when documented, or severe cognitive impairment preventing understanding of the tasks or participation in the training sessions.
  • Medical, neurological, orthopedic, or sensory condition that would contraindicate participation in motor training.
  • Uncontrolled epilepsy or any unstable medical condition that could interfere with participation.
  • Severe behavioral difficulties making repeated assessment or motor training impossible.
  • Ongoing participation in another interventional study that could interfere with the outcomes of this study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Aurélien D'Ignazio, MSc (PhD studend) contact

+33 6 89 56 66 43

aurelien.d-ignazio@polesante.eu

France1 site
  • Groupe Hospitalier Nord-Essonne

    Bures-sur-Yvette, Essone, 91440

    Aurélien D'Ignazio, MSc, PhD student, +33 6 89 56 66 43, aurelien.d-ignazio@polesante.eu

Other trials in France

About this study

Official title: Evaluation of the Effectiveness of the Neuromotor Task Training Approach in the Rehabilitation of Motor Difficulties in Children With Autism Spectrum Disorder: A Single-Case Experimental Design Study

The goal of this clinical study is to learn whether Neuromotor Task Training (NTT) may help improve functional motor skills in autistic children who have motor difficulties.

The main question it aims to answer is:

Read more

Does Neuromotor Task Training help autistic children improve a motor skill that is difficult for them in daily life?

This study will include autistic children with motor difficulties. Each child will work on one functional motor skill chosen according to their needs and daily-life goals. Examples may include skills such as catching a ball, jumping rope, putting on a coat, or another meaningful motor task.

Participants will take part in an initial assessment of their motor abilities. They will then choose, with their family and the researcher, a functional motor skill to work on. The selected skill will be assessed repeatedly before, during, and after the training period. Participants will receive Neuromotor Task Training sessions focused on this skill. They will also be followed after the training period to see whether the motor skill is maintained.

Neuromotor Task Training is a task-oriented rehabilitation approach. It focuses on practicing meaningful motor skills in conditions that are progressively adapted to the child. The task, the environment, and the feedback provided by the therapist may be adjusted during the sessions to support motor learning.

This study uses a single-case experimental design. This means that each participant's progress is measured repeatedly over time. The researchers will examine whether motor performance changes after the start of the training and whether these changes are maintained after the training period.

Read the detailed description

Autism spectrum disorder is frequently associated with motor difficulties that may affect autonomy, participation in daily activities, and quality of life. These difficulties may involve balance, coordination, motor planning, object manipulation, fine motor skills, gross motor skills, or the learning of functional motor skills. This study evaluates the use of Neuromotor Task Training (NTT), a task-oriented rehabilitation approach, in autistic children with motor difficulties.

The study will include 12 autistic children aged 6 to 10 years who present motor difficulties. Participants will be recruited in the context of their usual clinical care pathway, including child and adolescent mental health or medico-psychological services. Inclusion will require a diagnosis of autism spectrum disorder, an intelligence quotient of 70 or above, and motor difficulties documented through clinical assessment and standardized motor assessment. Standardized assessments may include the Movement Assessment Battery for Children, Third Edition (MABC-3), and the Developmental Coordination Disorder Questionnaire (DCD-Q), in order to document the presence and severity of motor difficulties in daily life.

The study uses a concurrent multiple-baseline single-case experimental design replicated across three successive cohorts of four participants. This design is well suited to the evaluation of individualized rehabilitation approaches in small clinical samples. Each participant serves as their own control through repeated measurements across successive study phases. Within each cohort, the introduction of the intervention will be staggered across participants to provide multiple opportunities to demonstrate an intervention effect at different points in time. Replication of the experimental procedure across three independent cohorts is intended to strengthen the internal validity of the study.

The study procedure includes four main stages: inclusion and initial assessment, pre-intervention baseline, intervention, and post-intervention follow-up.

During the inclusion and initial assessment stage, eligibility criteria will be checked. Motor difficulties will be documented using standardized motor tools and clinical assessment. The child's ability to understand and participate in the motor training sessions will also be considered. Written informed consent will be obtained from the child's legal representative(s), and the child's assent will be sought whenever possible according to age and level of understanding.

The pre-intervention baseline phase will last approximately 6 to 9 weeks. During this phase, the child, family, and researcher or therapist will identify one meaningful functional motor skill that is difficult for the child in daily life. Examples may include catching a ball, jumping rope, putting on a coat, cutting with scissors, or another functional task relevant to the child's autonomy and participation. The selected target skill will be defined in measurable terms so that repeated performance assessments can be conducted throughout the study.

During the baseline phase, the primary outcome will be assessed once weekly. In accordance with the What Works Clearinghouse single-case design standards (Version 5.0), each participant will complete a minimum of six baseline assessments. Within each cohort, introduction of the intervention will be staggered across participants, resulting in baseline phases of approximately 6, 7, 8, and 9 weeks, respectively. Baseline measurements will continue for participants who have not yet entered the intervention phase. Individualized goals will also be formalized using Goal Attainment Scaling (GAS), and a sensory profile assessment will be administered to identify sensory preferences, sensitivities, or aversions that may influence the child's engagement, learning conditions, response to feedback, or tolerance of the practice environment.

The intervention phase will consist of 10 Neuromotor Task Training sessions. NTT is a task-oriented rehabilitation approach based on the direct practice of meaningful motor tasks. The intervention focuses on a functional motor skill selected according to the child's needs, family priorities, and clinical assessment. The therapist analyzes the task requirements, including spatial, temporal, sequential, coordinative, and environmental demands. The therapist also analyzes the child's performance in order to identify factors that may limit successful task execution.

During the NTT sessions, task constraints, environmental conditions, and individual support will be adjusted progressively. These adaptations may include changes in distance, speed, object size, spatial organization, task complexity, attentional demands, or environmental constraints. Instructions, demonstrations, practice structure, and feedback will be adapted according to the child's stage of motor learning and sensory profile. Feedback may focus on the result of the action, the quality of movement, or environmental cues that help the child adjust their performance. The aim is to support the emergence, stabilization, and generalization of more efficient motor coordination.

Repeated motor performance measurements will be collected during each intervention session. The performance metric will be selected according to the target skill and will be objective, functional, and sensitive to change. Examples may include the number of successful trials, time needed to complete the task, accuracy, or another task-specific quantitative indicator. These repeated measurements will make it possible to describe each participant's learning trajectory over time.

To limit assessment bias, motor performance measures may be video-recorded and rated secondarily by an external outcome assessor who is not involved in the training sessions. When feasible, the assessor will be masked to the study phase. This procedure is intended to improve the reliability of outcome assessment while taking into account the practical constraints of a rehabilitation study conducted in a clinical setting.

After the 10-session intervention phase, a post-intervention follow-up phase will be conducted for approximately 3 to 5 weeks. During this phase, repeated performance measurements will continue without active NTT training on the target skill. This phase will allow the researchers to examine whether the acquired motor performance is maintained after the intervention. The follow-up phase will also help document retention and possible generalization of the motor skill to daily-life contexts, such as home, school, or other relevant environments.

Goal Attainment Scaling will be rated after completion of the 10-session intervention and again at the end of the 5-week follow-up phase to quantify the extent to which the individualized functional goal has been achieved and maintained. The MABC-3 will be used at baseline to characterize participants' motor difficulties and will not constitute a pre-specified intervention outcome.

The primary focus of the study is the change in performance on the individualized functional motor skill across baseline, intervention, and follow-up phases. Visual analysis of repeated performance data will be used to examine level, trend, slope, stability, immediacy of effect, overlap between phases, and maintenance of gains. Statistical analyses adapted to single-case experimental designs may also be used, including non-overlap indices such as Tau-U or modified Tau-U, in order to quantify the magnitude of change between phases.

Secondary and exploratory analyses may examine individual learning profiles, variability of response to NTT, maintenance of gains, and the possible contribution of sensory profile characteristics to intervention adaptation. When appropriate, exploratory analyses may also use dimensional reduction or clustering approaches to describe patterns of response across participants. These analyses will remain exploratory and will be interpreted with caution because of the small sample size and individualized nature of the intervention.

This study is designed to provide clinically relevant information about the implementation of task-oriented motor rehabilitation in autistic children with motor difficulties. It aims to document whether NTT may help improve meaningful functional motor skills, how performance changes over time, and under which clinical conditions this approach may be adapted to the needs of autistic children.

Being tested
Neuromotor Task Training
Keywords
Developmental Coordination Disorder, Motor Skills, Motor Difficulties, Motor Learning, Motor Rehabilitation, Neuromotor Task Training, Single-Case Experimental Design, Task-Oriented Training
Medical subject headings
Autism Spectrum Disorder, Motor Skills Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuromotor Task TrainingBehavioural

    Neuromotor Task Training is a task-oriented rehabilitation approach focused on the practice of meaningful functional motor skills. The therapist analyzes the selected task and adapts task constraints, environmental conditions, practice organization, and feedback to support motor learning. In this study, each participant will receive Neuromotor Task Training sessions targeting an individualized motor skill selected before the intervention phase.

Study groups in NCT07797439
Study groupRoleWhat they receive
Neuromotor Task TrainingExperimentalParticipants will be enrolled in three successive cohorts of four children. All participants will receive Neuromotor Task Training focused on an individualized functional motor skill. The cohort structure is used to support replication within the single-case experimental design. It does not correspond to different intervention groups.
Receives: Behavioral: Neuromotor Task Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance on the Individualized Functional Motor Skill

    Motor performance will be assessed using one predefined, task-specific, directly observable quantitative indicator for each individualized functional motor skill. Depending on the selected skill, the indicator may be the number or proportion of successful trials, completion time, accuracy, or another objective task-specific measure. The indicator and the direction indicating improvement will be defined before baseline and will remain unchanged throughout baseline, intervention, and follow-up. Each skill and participant will be analyzed separately in the original unit of measurement; data from different task-specific indicators will not be aggregated.

    Measured: Once weekly during the 6- to 9-week baseline phase, at each of the 10 intervention sessions, and once weekly during the 5-week post-intervention follow-up phase.

Secondary outcomes (1)
  1. Goal Attainment Scaling Attainment Level

    Attainment of the individualized functional motor goal will be assessed using Goal Attainment Scaling (GAS). Goal achievement is rated on a five-point ordinal scale ranging from -2 to +2, where -2 indicates a level much lower than the expected outcome, -1 a level lower than expected, 0 the expected level of attainment, +1 a level higher than expected, and +2 a level much higher than expected. Higher scores indicate greater goal attainment.

    Measured: At baseline goal setting, after completion of the 10-session intervention, and at the end of the 5-week follow-up phase.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionJun 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Single-case experimental design using a concurrent multiple-baseline design replicated across three successive cohorts of four participants. Within each cohort, introduction of Neuromotor Task Training will be staggered across participants, with baseline phases lasting approximately 6, 7, 8, and 9 weeks. All participants will receive the intervention targeting an individualized functional motor skill. Each participant will serve as their own control through repeated measurements collected during baseline, intervention, and follow-up phases.
Masking
None (open label)
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07797439
Sponsor's protocol ID
GHNE-NTT-TSA-SCED
Other IDs
2026-A00093-48
Acronym
NTT-SCED
Status last verified
Sep 2026
First submitted
24 Aug 2026
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because the study includes a small sample of children and may involve sensitive clinical and video-recorded data. Sharing individual-level data could increase the risk of participant identification. Aggregated and anonymized results may be shared in scientific publications.

Questions about this trial

What is this clinical trial studying?

A study testing Neuromotor Task Training in people with Autism Spectrum Disorder (ASD), run by Groupe Hospitalier Nord-Essonne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aurélien D'Ignazio, MSc (PhD studend) (+33 6 89 56 66 43, aurelien.d-ignazio@polesante.eu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance on the Individualized Functional Motor Skill (time frame: Once weekly during the 6- to 9-week baseline phase, at each of the 10 intervention sessions, and once weekly during the 5-week post-intervention follow-up phase.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in